- Associated Press•15 hours ago
The San Rafael, California-based company said it had a loss of 26 cents per share. Earnings, adjusted for one-time gains and costs, were 1 cent per share. The results surpassed Wall Street expectations. ...
- GlobeNewswire•16 hours ago
-Third Quarter 2016 Total BioMarin Revenues Increase 34% Year over Year to $280 million. -Vimizim Net Product Revenues Increase 25% Year over Year to $81 million in the Third Quarter 2016. -Kuvan Net Product ...
BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||73.00 x 100|
|Ask||93.50 x 100|
|Day's Range||80.30 - 83.39|
|52wk Range||62.12 - 118.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-24.65|
|Avg Vol (3m)||1,399,044|
|Dividend & Yield||N/A (N/A)|